Cancer News and Research

Latest Cancer News and Research

New siRNA treatment reduces damaging inflammation in animals models of several disorders

Massachusetts General Hospital (MGH) researchers - along with collaborators from Massachusetts Institute of Technology (MIT) and Alnylam Pharmaceuticals - have found a way to block, in an animal model, the damaging inflammation that contributes to many disease conditions.

10 Oct 2011

First successful quantification of membrane lipids in a living cell

Could controlling cell-membrane fat play a key role in turning off disease? Researchers at the University of Illinois at Chicago think so, and a biosensor they've created that measures membrane lipid levels may open up new pathways to disease treatment.

10 Oct 2011

Researchers focus on gelatinase inhibitor compounds to treat neurological diseases

Results of a study by a group of University of Notre Dame researchers represent a promising step on the road to developing new drugs for a variety of neurological diseases.

10 Oct 2011

MicroRNA-101 can block autophagy in cancer cells

All cells in our body have a system that can handle cellular waste and release building blocks for recycling. The underlying mechanism is called autophagy and literally means "self-eating". Many cancer cells have increased the activity of this system and the increased release of building blocks equip the cancer cells with a growth advantage and can render them resistant towards treatment.

10 Oct 2011

Study identifies three new chromosomal regions implicated in susceptibility to melanoma

The genomic analysis technologies enable the study of genetic factors related to numerous diseases. In few areas this researches brought such a big and useful volume of information as in the case of melanoma.

10 Oct 2011

NCI selects UT Southwestern, Parkland to improve colorectal cancer screening

The National Cancer Institute (NCI) has selected UT Southwestern Medical Center and Parkland Health & Hospital System as a national site to improve screening for colorectal cancer, the nation's No. 3 cancer killer.

10 Oct 2011

Advocates prepare for battle on PSA testing; insurers review options

A day after a government panel said that healthy men should no longer get screened for prostate cancer, some doctors' groups and cancer patients' advocates began a campaign to convince the nation that the advice was misguided. Their hope is to copy the success of women's groups that successfully persuaded much of the country two years ago that it was a mistake for the same panel, the United States Preventive Services Task Force, to recommend against routine mammograms for women in their 40s.

10 Oct 2011

Boehringer Ingelheim receives FDA approval for COMBIVENT RESPIMAT to treat COPD

Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved COMBIVENT RESPIMAT, a new, propellant-free inhaler product that uses a slow-moving mist to deliver the same active ingredients of COMBIVENT Inhalation Aerosol in a metered dose inhaler.

10 Oct 2011

UNC professor to co-direct Barrett's Esophagus Translational Research Network projects

A University of North Carolina at Chapel Hill researcher is one of five co-principal investigators in a new collaborative network created to study genetic determinants of Barrett's esophagus and esophageal adenocarcinoma.

10 Oct 2011

Novartis, IBM announce NCD Challenge

IBM and Novartis today announced the NCD Challenge, a competition among a number of the world's leading universities designed to tap the inventiveness of students to find new ways to address the rise of non-communicable diseases in both developing and developed countries.

10 Oct 2011

First COX-2-targeted PET imaging agent for use in animal models of inflammation, cancer

A series of novel imaging agents could make it possible to "see" tumors in their earliest stages, before they turn deadly.

10 Oct 2011

UMass Amherst SPHHS wins HHS award to create Public Health Training Center

Training to improve the nation's public health system by strengthening the technical, scientific, managerial and leadership competence of current and future public health workers will soon be underway in Springfield, Holyoke, Pittsfield and the Berkshires, supported by a four-year, $2.5 million grant to the School of Public Health and Health Sciences (SPHHS) at the University of Massachusetts Amherst.

10 Oct 2011

A new approach to cancer treatment

Scientists have discovered a mechanism that causes an aggressive type of lung cancer to re-grow following chemotherapy, offering hope for new therapies.

9 Oct 2011

NIH awards LSUHSC $9 million grant to develop pneumonia vaccine

Dr. Judd Shellito, Chief of the Section of Pulmonary and Critical Care Medicine at LSU Health Sciences Center New Orleans, has been awarded approximately $9 million in grant funding to develop a vaccine against Pneumocystis, an important cause of pneumonia in people with HIV infection. This potentially fatal illness is the most common serious opportunistic infection in people with HIV.

7 Oct 2011

Many cancer screenings may be unnecessary

Forty Percent Of Medicare Spending On Common Cancer Screenings Unnecessary, Probe Suggest Cancer screening tests are vastly overused in the United States, with about 40 percent of Medicare spending on common preventive screenings regarded as medically unnecessary, an iWatch News investigation reveals.

7 Oct 2011

Smoking susceptibility of young people linked to tobacco displays

Young people who find tobacco displays in shops attractive and who easily recall seeing the displays have a greater chance of becoming a smoker according to a new Cancer Research UK funded research study published in Nicotine and Tobacco Research today.

7 Oct 2011

Healthy people analysis: Nation's overall health improves, but disparities persist

Minorities and low-income groups continue to be less likely to have a regular source of medical care, despite a decade of efforts to reverse this circumstance.

7 Oct 2011

Health Robotics to unveil i.v.STATION ONCO oncology robot at 46th midyear ASHP

Health Robotics today announced that it plans to unveil its revolutionary 2nd generation oncology robot i.v.STATION ONCO at the American Society of Health System Pharmacists (ASHP) 46th Midyear Clinical Meeting & Exhibition, to be held at New Orleans, Louisiana on December 4-8 2011.

7 Oct 2011

CEL-SCI closes previously announced registered direct offering

CEL-SCI Corporation announced today that it has closed its previously announced registered direct offering for the sale of (i) 13,333,334 shares of its common stock at a price per share of $0.30 and (ii) warrants to purchase up to 12,000,000 shares of CEL-SCI Corporation's common stock at a purchase price of $0.40. The warrants may be exercised at any time prior to October 6, 2014.

7 Oct 2011